Cardarine (GW-501516 / Endurobol) – Endurance, Fat Loss & Metabolic Optimization

Cardarine (GW-501516) is a potent PPARδ (Peroxisome Proliferator-Activated Receptor delta) agonist, originally developed by Ligand Pharmaceuticals and GlaxoSmithKline to treat metabolic syndrome, obesity, and cardiovascular disease. Although pharmaceutical development was discontinued after long-term animal trials, Cardarine remains widely studied in research for its unique ability to promote fat metabolism, enhance endurance, and support cardiovascular function.

Unlike SARMs, Cardarine is non-hormonal, making it a common addition to SARM stacks for cutting or endurance purposes. Its primary performance benefits come from its ability to increase mitochondrial activity, stimulate fatty acid oxidation, and improve VO₂ max, making it especially valued in sports, athletics, and endurance-focused research.

💊 Key Details

• Compound: GW-501516 (Cardarine / Endurobol)
• Category: PPARδ Agonist (not a SARM)
• Original Development: Metabolic & cardiovascular therapies
• Form: Oral – excellent bioavailability

✅ Research-Backed Benefits

• Enhances fat burning & metabolic efficiency
• Increases aerobic capacity and endurance
• Helps preserve lean muscle during caloric restriction
• Non-hormonal → no testosterone suppression
• May support lipid balance & cardiovascular health

📦 Common Research Applications

• Endurance & stamina enhancement studies
• Fat oxidation & weight management protocols
• Non-hormonal performance support
• Athletic & cardiovascular conditioning research

⚡ Cardarine (GW-501516) stands out in the enhancement field for its unique metabolic properties, shifting the body’s energy preference from glucose to fat. This mechanism is why it continues to attract significant attention in performance science, endurance sports, and fat-loss research.